Kazia Therapeutics
Sydney, 26 May 2023 – Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, today attended and participated in the Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) & Diffuse Intrinsic Pontine Glioma (DIPG) at the White House, held on Thursday, 25 May, 2023, United States’ time.
In alignment with President Joe Biden and First Lady Jill Biden’s commitment to end cancer, the forum brought together patients, caregivers, oncologists, researchers, and government officials to discuss and spur action against rare adult and pediatric cancers.
/Public Release.
